Bicycle Therapeutics

About Bicycle Therapeutics

Bicycle Therapeutics is a pioneering biotechnology company based in the UK, dedicated to transforming the treatment landscape for patients with cancer and other serious diseases. The company leverages its proprietary Bicycle platform technology to develop a new class of therapeutics known as Bicycles, which are designed to target and engage specific disease pathways with high precision.

Founded by a team of experienced scientists and industry veterans, Bicycle Therapeutics aims to create innovative therapies that can improve patient outcomes while minimizing side effects. The company’s lead product candidates are currently in various stages of clinical development, showcasing the potential of Bicycles to address unmet medical needs.

• Innovative Technology: Bicycle Therapeutics utilises a unique approach to drug design, enabling the creation of small, stable, and highly selective therapeutic agents.
• Focus on Oncology: The primary focus of the company is on developing treatments for cancer, with several promising candidates undergoing clinical trials.
• Commitment to Patients: Bicycle Therapeutics is committed to improving the lives of patients by delivering effective and safe therapies that can make a real difference.

With a strong emphasis on research and development, Bicycle Therapeutics collaborates with leading academic institutions and industry partners to advance its pipeline of innovative therapies. The company is also dedicated to fostering a culture of scientific excellence and integrity, ensuring that all its activities align with the highest ethical standards.

As Bicycle Therapeutics continues to grow, it remains focused on its mission to revolutionise the treatment of serious diseases through cutting-edge science and technology. The company is poised to make significant contributions to the field of biotechnology, ultimately aiming to bring hope to patients worldwide.